x
Disclaimer
This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
is ushering in a new era of brain disorder treatment. BrainsWay is continuously seeking to expand its platform, achieving outcomes not thought possible with traditional medical solutions. Through ongoing investment in R&D and in research initiatives ranging from large-scale multicenter trials to personalized medicine studies, BrainsWay represents the next-generation of treatments for depression and OCD.
Why treat Depression & OCD with BrainsWay Deep TMS?
For
Patients
- FDA-cleared treatment
- Effective, even when medication doesn’t work*
- Short 20-minute sessions
- Non-invasive
- No systemic side effects
- MDD treatment is covered by Medicare and majority of private insurers
Our Treatments
*See response and remission rates in the MDD and OCD treatment pages
For Healthcare
Professionals
- Clinically Proven
- Deeper, Broader Stimulation
- Most robust clinical pipeline
- Financially attractive business model
- Best-in-class customer support
- Provide patients with alternative treatment when medication has proven ineffective
BrainsWay Can Help These Brain Disorders
-
Obsessive Compulsive Disorder (OCD) Treatment
BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD.
-
Major Depressive Disorder (MDD) Treatment
Major Depressive Disorder is a neuropsychiatric disorder that is expressed in emotional, physiological and behavioral effects.
BrainsWay By The Numbers
-
500K+
TREATMENTS DELIVERED
-
17
COUNTRIES
-
90%
OF POPULATION IS COVERED BY REIMBURSEMENT